BharatTechIND reports the drugmaker is widening its semaglutide lineup to get around supply problems with Obeda and grow in India's weight loss market.
Recap by typeshit. Post by @BharatTechIND on X.
A Facebook user criticizes telehealth marketing of tirzepatide and other GLP-1 services that targets new mothers, calling it predatory. One person's opinion.
Dr. Noc joined StarTalk to cover GLP-1 drugs, creatine, peptides and looksmaxxing. The full talk is out on YouTube and in podcast apps.
The obesity doctor says commenters once treated her early support for these medications as heresy. She adds that she saw their potential back in 2005.
A TikTok playlist collects GLP-1 updates from creator @stephaniemua1. There is no detail on what the videos cover beyond the playlist name.
Bazaar India's new issue looks at collagen loss and skin laxity concerns tied to fast GLP-1 weight loss, and how beauty brands are responding.
GLP-1 drugs come with side effects from hair loss to severe stomach trouble. SheKnows looks at a newer drug class researchers hope will be easier to tolerate.
Loading…